NCT00659399 2015-03-18Feasibility Study of Short Term Fondaparinux (Arixtra) in Chemotherapy-Pretreated Ovarian Carcinoma Patients at High Risk of ProgressionNYU Langone HealthPhase 1 Withdrawn